Show simple item record

dc.contributor.authorCalmann, Melissa A.
dc.contributor.authorMarinus, Martin G.
dc.date2022-08-11T08:08:54.000
dc.date.accessioned2022-08-23T16:11:22Z
dc.date.available2022-08-23T16:11:22Z
dc.date.issued2004-09-18
dc.date.submitted2008-08-15
dc.identifier.citationProc Natl Acad Sci U S A. 2004 Sep 28;101(39):14174-9. Epub 2004 Sep 16. <a href="http://dx.doi.org/10.1073/pnas.0406104101">Link to article on publisher's site</a>
dc.identifier.issn0027-8424 (Print)
dc.identifier.doi10.1073/pnas.0406104101
dc.identifier.pmid15375217
dc.identifier.urihttp://hdl.handle.net/20.500.14038/33149
dc.description.abstractHuman cell lines and Escherichia coli dam mutants are sensitive to the cytotoxic action of the anticancer agent, cisplatin. Introduction of mutations disabling DNA mismatch repair into these cell lines renders them resistant to the action of this drug. We used RecA-mediated strand exchange between homologous phiX174 molecules, one that was platinated and the other that was unmodified, to show that strand transfer is decreased in a dose-dependent manner. Transfer was severely decreased at 10 adducts per molecule (5,386 bp) and abolished with 24 adducts. At low levels of adduction, addition of MutS to the reaction further decreases the rate and yield in a dose-dependent manner. MutL addition was without effect even in the presence of MutS. The results suggest that although mismatch repair is beneficial for mutation avoidance, its antirecombination activity on inappropriate substrates can be lethal to the cell.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15375217&dopt=Abstract ">Link to article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1073/pnas.0406104101
dc.subjectAdenosine Triphosphatases; Antineoplastic Agents; Bacterial Proteins; Base Pair Mismatch; Cell Survival; Cisplatin; DNA; DNA Adducts; DNA Repair; DNA Repair Enzymes; DNA, Single-Stranded; DNA-Binding Proteins; Escherichia coli; Escherichia coli Proteins; MutS DNA Mismatch-Binding Protein; Nucleic Acid Conformation; Rec A Recombinases; Recombination, Genetic; Site-Specific DNA-Methyltransferase (Adenine-Specific)
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleMutS inhibits RecA-mediated strand exchange with platinated DNA substrates
dc.typeJournal Article
dc.source.journaltitleProceedings of the National Academy of Sciences of the United States of America
dc.source.volume101
dc.source.issue39
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/169
dc.identifier.contextkey580021
html.description.abstract<p>Human cell lines and Escherichia coli dam mutants are sensitive to the cytotoxic action of the anticancer agent, cisplatin. Introduction of mutations disabling DNA mismatch repair into these cell lines renders them resistant to the action of this drug. We used RecA-mediated strand exchange between homologous phiX174 molecules, one that was platinated and the other that was unmodified, to show that strand transfer is decreased in a dose-dependent manner. Transfer was severely decreased at 10 adducts per molecule (5,386 bp) and abolished with 24 adducts. At low levels of adduction, addition of MutS to the reaction further decreases the rate and yield in a dose-dependent manner. MutL addition was without effect even in the presence of MutS. The results suggest that although mismatch repair is beneficial for mutation avoidance, its antirecombination activity on inappropriate substrates can be lethal to the cell.</p>
dc.identifier.submissionpathgsbs_sp/169
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages14174-9


This item appears in the following Collection(s)

Show simple item record